| Synonyms: | |
| Status: | Approved (2018) |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| ATC: | L01XX67 |
| UNII: | 8ZHS5657EH |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Elongation factor 2 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Leukemia, Myeloid, Acute | 4 | D015470 | ClinicalTrials |
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 2 | D000099067 | ClinicalTrials |
| Leukemia, Myelomonocytic, Chronic | 1 | D015477 | ClinicalTrials |
| Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
| Primary Myelofibrosis | 1 | D055728 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297573 |
| FDA SRS | 8ZHS5657EH |
CONTENTS